Devices › Device types
FDA product code FAE · class 2 · Gastroenterology, Urology
Prosthesis, penile: medical device reports filed with FDA
2,776 reports carry this product code, 1992–2026; 15 brands with a page.
- 2,776
- reports with this product code
- 0% of all MAUDE reports
- 199
- reports, 12 months to August 2026
- 200 in the 12 months before
- 8.5%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code FAE is FDA's classification for "Prosthesis, penile" (gastroenterology, Urology panel), a class 2 device. 2,776 medical device reports carry this product code, 0% of the MAUDE database, from March 1992 to August 2026.
199 reports arrived in the 12 months to August 2026, close to the 200 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (90.7%), malfunction (8.5%) and other (0.4%). 15 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| AMS Spectra Concealable Penile Prosthesis | 953 | 10 | 0.1% | 4.4% |
| Tactra Malleable Penile Prothesis | 454 | 51 | 0% | 4.6% |
| Malleable Penile Prosthesis | 284 | 0 | 0% | 0.7% |
| Spectra | 39 | 8 | 3% | 12.2% |
| AMS Inflatable Penile Prosthesis | 23 | 687 | 0% | 7.5% |
| Inflatable Penile Prosthesis | 23 | 8 | 0% | 0.7% |
| Titan | 10 | 0 | 0% | 23.8% |
| Alpha I | 8 | 0 | 0% | 0.7% |
| AMS Ambicor Penile Prosthesis | 6 | 28 | 0% | 10.5% |
| Genesis | 6 | 0 | 0.1% | 1.9% |
| Ambicor Penile Prosthesis | 3 | 0 | 0% | 0.6% |
| Surgitek | 3 | 0 | 1.3% | 14.3% |
| Hydroflex Penile Prosthesis | 1 | 0 | 0% | 0.6% |
| Mentor | 1 | 0 | 0.1% | 30.1% |
| Titan Touch Scro Zero Ang 22cm | 1 | 0 | 0% | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| American Medical Systems | 662 | 23.8% |
| Coloplast A/S | 361 | 13% |
| American Medical Systems Mn | 282 | 10.2% |
| Mentor | 23 | 0.8% |
| Mentor - Minnesota Division | 11 | 0.4% |
| Medical Engineering | 8 | 0.3% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Insufficient device problem information | 860 | 31% |
| Inadequacy of device shape and/or size | 152 | 5.5% |
| Mechanical problema mechanical problem | 141 | 5.1% |
| Defective devicethe device was defective | 94 | 3.4% |
| Migrationthe device moved from where it was placed | 81 | 2.9% |
| Explanted | 74 | 2.7% |
| Device operates differently than expectedthe device behaved unexpectedly | 66 | 2.4% |
| Fracturea broken bone | 52 | 1.9% |
| Malposition of device | 48 | 1.7% |
| Breakthe device broke | 42 | 1.5% |
| Migration or expulsion of device | 36 | 1.3% |
| Extrusion | 31 | 1.1% |
| Material erosion | 30 | 1.1% |
| Inflation problem | 29 | 1% |
| Device inoperablethe device could not be used | 19 | 0.7% |
| Leak/splashthe device leaked | 18 | 0.6% |
| Fluid/blood leak | 15 | 0.5% |
| Material puncture/hole | 14 | 0.5% |
| Nonstandard device | 14 | 0.5% |
| Replace | 14 | 0.5% |
Questions about prosthesis, penile reports
What is product code FAE?
FDA's classification code for "Prosthesis, penile", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,776 reports through August 2026, 199 of them in the latest 12 months.
Which brands appear most often?
AMS Spectra Concealable Penile Prosthesis (953), Tactra Malleable Penile Prothesis (454), Malleable Penile Prosthesis (284), Spectra (39) and AMS Inflatable Penile Prosthesis (23). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.